- Introduction: Scientific Writing goes Digital
AI-powered tools are reshaping how Medical Affairs teams develop scientific publications.
MA can now accelerate evidence synthesis, improve consistency, and collaborate more efficiently across global teams — turning a process that once took months into one that can be measured in days.
Practical example: A manuscript that traditionally required six weeks of literature review, drafting, and internal alignment before it reached a first complete version can now reach that same 90%-ready stage in a matter of hours with the right AI-assisted workflow — leaving the team’s time for what actually needs human judgement: interpretation, positioning, and scientific accuracy.
- The Current State of Scientific Writing
Challenges today:
- Time-intensive literature review and data synthesis
- Multiple contributors creating version-control issues
- Repetitive review cycles and delayed approvals
- Risk of inconsistencies across complex scientific documents
Early adopters use AI-assisted writing, shared workspaces, and digital review tools.
Practical tip: Before adopting any AI writing tool, map your current publication timeline stage by stage — concept, literature review, first draft, internal review, submission. Most teams find that 60–70% of total time is lost not in the writing itself, but in review cycles and version reconciliation between contributors. That’s the stage where digital collaboration tools deliver the fastest win, often before AI drafting is even introduced.
- The Roadmap to AI-Enabled Scientific Writing
Phase 1: AI-Assisted Preparation
- Summarise literature and scientific data
- Identify key messages and evidence gaps
- Generate structured outlines and initial drafts
Practical example: Instead of manually screening 40+ papers for a congress abstract, a medical writer can use an AI tool to summarise the relevant literature into key findings, flag where evidence is thin, and produce a structured first draft — reducing preparation time from days to hours, while the writer retains full control over interpretation and framing.
Phase 2: Collaborative Development
- Enable real-time co-authoring and commenting
- Consolidate feedback from multiple stakeholders
- Maintain a single controlled version of the document
Practical tip: Assign one “version owner” per document even when using real-time collaborative platforms. Shared editing reduces version-control chaos, but a single point of accountability for merging feedback prevents scientific nuance from getting lost when multiple reviewers comment simultaneously.
Phase 3: Intelligent Quality Control
- Detect inconsistencies and duplicated information
- Support terminology, data, and reference checks
- Track revisions and support final scientific review
Practical example: An AI-supported quality check can flag a discrepancy between a stated p-value in the results section and the same value cited in the discussion — a catch that’s easy to miss manually across a 20-page manuscript but takes seconds for a properly configured tool to surface for human review.
- Enablers of Smarter Scientific Writing
- People: Medical writers, MA leads, subject-matter experts, publication teams
- Processes: structured review cycles, defined approvals, standardised workflows
- Technology: AI writing tools, shared document platforms, reference management systems
- Governance: human oversight, data protection, publication ethics, AI-use policies
Practical tip: Governance should be defined before a tool is rolled out, not after. A simple one-page AI-use policy — covering what can and cannot be AI-drafted, who reviews AI-generated text, and how sources are verified — prevents the most common early-adoption mistakes and builds trust across the publication team from day one.
This is precisely where purpose-built platforms are beginning to change the equation. ReSkript, MphaR’s AI-powered clinical document drafting platform, is designed around this exact enabler stack — bringing structured workflows, human oversight, and AI drafting together in one environment, rather than leaving teams to stitch together generic tools. ReSkript produces manuscript and congress abstract drafts that are approximately 90% ready in 2–3 hours, giving medical writers a strong scientific starting point while keeping full editorial and scientific control in human hands.
- Measuring Efficiency and Scientific Impact
Metrics beyond publication volume:
- Time from concept to first draft
- Number of review and revision cycles
- Time required to consolidate feedback
- Number of inconsistencies detected before approval
- Scientific accuracy and stakeholder satisfaction
AI and collaboration tools can shorten publication timelines while supporting quality and consistency.
Practical example: A team using AI-assisted drafting for congress abstracts might track “time from concept to first draft” as their primary efficiency metric. If that number falls from an average of 5 days to under 1 day — without an increase in factual errors caught at review — that’s a clear, defensible measure of AI’s contribution to the publication process, and one that’s easy to report to leadership.
- Conclusion: The Future of Scientific Writing
Medical Affairs is moving from fragmented, manual writing processes toward connected and AI-supported publication workflows.
The strongest model combines AI efficiency, collaborative technology, and human scientific expertise to deliver accurate publications faster.
This is the shift ReSkript was built for. Rather than treating AI as a bolt-on tool, ReSkript embeds AI drafting directly into the manuscript and abstract workflow — helping Medical Affairs teams move from blank page to 90%-ready draft in 2–3 hours, without compromising the scientific rigour and human judgement that every publication depends on. For teams ready to see what this looks like in practice, a sample draft is the fastest way to understand the difference.